Search Results
Search for other papers by Shakeel Kautbally in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by François Jamar in
Google Scholar
PubMed
Search for other papers by Michel Mourad in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is a common autoimmune disorder mainly characterized by an abnormal production of antibodies binding to and activating TSH receptor, referred to as thyroid-stimulating immunoglobulins (TSI), thereby leading to
Search for other papers by Nadine Johnson in
Google Scholar
PubMed
Search for other papers by Vikash Chatrani in
Google Scholar
PubMed
Search for other papers by Anna-Kay Taylor-Christmas in
Google Scholar
PubMed
Search for other papers by Eric Choo-Kang in
Google Scholar
PubMed
Search for other papers by Monica Smikle in
Google Scholar
PubMed
Search for other papers by Rosemarie Wright-Pascoe in
Google Scholar
PubMed
Search for other papers by Karen Phillips in
Google Scholar
PubMed
Search for other papers by Marvin Reid in
Google Scholar
PubMed
Introduction Hypothyroidism is the most common disorder of thyroid function in pregnancy [ 1 ]. Subclinical hypothyroidism (SCH) is defined as serum thyroid-stimulating hormone (TSH) >97.5% and normal free thyroxine (FT 4 ), with or without
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Massimiliano Succi in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
and 2/6 (33%) on vandetanib. No patients in SELP treatment had a reduced response after ACTH stimulation. ACTH, adrenocorticotropic hormone; p #, patient ID; L, lenvatinib; V, vandetanib; S, selpercatinib. Table 2 Results of adrenal
Search for other papers by María de los Ángeles Garayalde Gamboa in
Google Scholar
PubMed
Search for other papers by Melina Saban in
Google Scholar
PubMed
Search for other papers by Marina Ines Curriá in
Google Scholar
PubMed
disease and thyroid surgery. Currently, the first-line treatment is oral levothyroxine (LT4). However, there are cases in whom the dose of oral LT4 is not sufficient to reverse the symptoms or thyroid-stimulating hormone (TSH) levels (TSH >4.5 mIU/L after
Internal Medicine, Erasmus MC, University Medical Center Rotterdam
Search for other papers by Sita Virakul in
Google Scholar
PubMed
Search for other papers by Leendert van Steensel in
Google Scholar
PubMed
Search for other papers by Virgil A.S.H. Dalm in
Google Scholar
PubMed
Department of Ophthalmology, Geneva University Hospitals, Geneva, Switzerland
Search for other papers by Dion Paridaens in
Google Scholar
PubMed
Internal Medicine, Erasmus MC, University Medical Center Rotterdam
Rotterdam Eye Hospital, Rotterdam, The Netherlands
Search for other papers by P. Martin van Hagen in
Google Scholar
PubMed
Search for other papers by Willem A. Dik in
Google Scholar
PubMed
processes contribute to orbital tissue expansion in GO. Autoantibodies directed against the thyroid stimulating hormone receptor (TSHR) are considered as important contributors to GO and TSHR autoantibody titers correlate positively with disease
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
Search for other papers by Claire L Wood in
Google Scholar
PubMed
Search for other papers by Niamh Morrison in
Google Scholar
PubMed
Search for other papers by Michael Cole in
Google Scholar
PubMed
Search for other papers by Malcolm Donaldson in
Google Scholar
PubMed
Wellcome Trust-MRC Institute of Metabolic Sciences, University of Cambridge, Cambridge, UK
Search for other papers by David B Dunger in
Google Scholar
PubMed
Search for other papers by Ruth Wood in
Google Scholar
PubMed
Department of Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Search for other papers by Simon H S Pearce in
Google Scholar
PubMed
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
Search for other papers by Timothy D Cheetham in
Google Scholar
PubMed
-diagnosis. We describe the detailed baseline characteristics of the cohort including the frequency of eye signs linked to thyrotoxicosis as well as initial change in BMI on ATD. We also examined the early serum thyroid-stimulating hormone (TSH) and free
Search for other papers by Sandrine Donadio-Andréi in
Google Scholar
PubMed
CARMEN-INSERM U1060, Université Claude Bernard Lyon 1, Faculté de Médecine et de Maïeutique Lyon Sud - Charles Mérieux, Oullins
Société Française de Médecine Nucléaire, Groupe de Biologie Spécialisée, Centre Antoine Béclère, Paris
Search for other papers by Karim Chikh in
Google Scholar
PubMed
Search for other papers by Christine Heuclin in
Google Scholar
PubMed
Search for other papers by Elisabetta Kuczewski in
Google Scholar
PubMed
CARMEN-INSERM U1060, Université Claude Bernard Lyon 1, Faculté de Médecine et de Maïeutique Lyon Sud - Charles Mérieux, Oullins
Société Française de Médecine Nucléaire, Groupe de Biologie Spécialisée, Centre Antoine Béclère, Paris
Search for other papers by Anne Charrié in
Google Scholar
PubMed
Laboratoire du Service de Médecine Nucléaire, Centre Hospitalier de Chambéry, Chambéry
Pôle de Biologie, Centre Hospitalier et Universitaire de Grenoble
UMR-S INSERM 1037, Grenoble, France
Search for other papers by Anne-Sophie Gauchez in
Google Scholar
PubMed
Search for other papers by Catherine Ronin in
Google Scholar
PubMed
Introduction Over the past years substantial variability among thyroid-stimulating hormone (TSH) measurements has been extensively described, largely influencing the critical discrimination between normal and diseased TSH levels [ 1 ]. To
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Marina Lugaresi in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Patrice Dufour in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Alessandro Manzo in
Google Scholar
PubMed
Search for other papers by Erika Carbone in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Corinne Charlier in
Google Scholar
PubMed
Center for Interdisciplinary Research on Medicines (C.I.R.M.), University of Liege (ULiège), CHU (B35), Liege, Belgium
Search for other papers by Catherine Pirard in
Google Scholar
PubMed
increased thyroid-stimulating hormone (TSH) levels ( 6 ), which have been found to represent a risk factor for thyroid cancer onset ( 7 ). Of EDCs, per- and poly-fluoroalkyl substances (PFAS), poly-chlorinated biphenyls (PCBs), and
Search for other papers by Érique José F. Peixoto de Miranda in
Google Scholar
PubMed
Search for other papers by Márcio Sommer Bittencourt in
Google Scholar
PubMed
Search for other papers by Itamar S. Santos in
Google Scholar
PubMed
Search for other papers by Paulo A. Lotufo in
Google Scholar
PubMed
Search for other papers by Isabela M. Benseñor in
Google Scholar
PubMed
Introduction The link between subclinical hypothyroidism (SCH), which is defined as high serum thyroid-stimulating hormone (TSH) concomitant with normal serum free thyroxine levels (fT 4 ) [ 1 ], and cardiovascular disease remains
Search for other papers by N. Papanikolaou in
Google Scholar
PubMed
Search for other papers by P. Perros in
Google Scholar
PubMed
diffuse goiter was observed. Her proximal muscles were significantly tender. Muscle power and tendon reflexes were within the normal range. Laboratory evaluation showed a suppressed serum thyroid stimulating hormone (TSH; <0.05 mU/l, normal range 0